Rhinovirus Statistics in US 2026 | Cases, Children, Symptoms & Facts

Rhinovirus in US data show that rhinoviruses cause more than half of all common colds nationwide, with over 500 million non-influenza respiratory infections occurring annually. As of September 2026, the CDC reports rhinovirus/enterovirus activity increasing nationally, children average 6 to 8 colds a year compared to 2 to 3 for adults, and the common cold’s economic toll exceeds $40 billion annually once medical costs and missed work are combined.

Rhinovirus in US 2026

Rhinovirus in US tracking show this virus remains the single most common cause of respiratory illness nationwide, year after year. According to the CDC, rhinoviruses are the most frequent cause of the common cold in the United States, and they’re also a common viral trigger for asthma attacks. Most infections cause no symptoms or only mild symptoms, but the virus can cause serious illness in people with weakened immune systems, asthma, or other underlying conditions, and there remains no vaccine or specific antiviral treatment available.

As of September 4, 2026, CDC surveillance data shows rhinovirus/enterovirus activity increasing nationally, a trend the agency describes as expected for this time of year even as overall acute respiratory illness activity stays very low. Rhinovirus in US compiled below break down case volume, pediatric impact, symptom patterns, seasonal surveillance, and the broader economic cost using the CDC’s most recent respiratory virus data alongside peer-reviewed clinical research.

Unlike influenza or RSV, rhinovirus doesn’t get its own dedicated CDC dashboard category; it’s tracked jointly with enterovirus under the shorthand “RV/EV” because the two virus families produce nearly identical respiratory symptoms and are often detected using the same laboratory test panels. That shared tracking approach means public awareness of rhinovirus specifically lags well behind its actual disease burden, even though it circulates more consistently throughout the year than almost any other respiratory pathogen the CDC monitors.

Interesting Facts About Rhinovirus in US 2026

Source: CDC National Center for Immunization and Respiratory Diseases and peer-reviewed cold-cost economic studies.

The Rhinovirus Statistics in US figures in this table reflect a virus so common that most people underestimate how much of the country’s respiratory illness burden it actually represents. Unlike influenza or RSV, which spike sharply during defined winter seasons, rhinovirus circulates essentially year-round, with the CDC noting its activity tends to peak specifically in spring and late summer through fall.

That year-round pattern is part of why the economic figures in this table stay so large even in years without a major flu season. The $40 billion baseline estimate, first calculated using 2000-2001 survey data, would exceed $56 billion once adjusted for inflation through recent years, and researchers note that figure likely undercounts the true cost given how routinely people treat cold symptoms without ever seeing a doctor.

Rhinovirus Case Numbers in the US 2026

Annual Non-Influenza Respiratory Infections (Colds) in the US
Total Colds Nationally    |████████████████████████████████████████ 500 million+
Caused by Rhinovirus      |████████████████████████ 50%+
Physician Visits          |██████████ 100 million+

Source: CDC respiratory virus surveillance and peer-reviewed rhinovirus epidemiology research.

The sheer scale of 500 million colds annually makes rhinovirus one of the most consistently active pathogens in the country, far outpacing seasonal illnesses like influenza in raw case volume even though it receives far less public attention. Because rhinovirus and enterovirus produce similar respiratory symptoms and are often detected using the same laboratory panels, the CDC tracks them jointly as a single RV/EV category in its national respiratory virus dashboard rather than reporting rhinovirus cases in complete isolation.

The 160-plus known rhinovirus strains help explain why reinfection happens so frequently throughout a person’s life and why no vaccine currently exists. Immunity built against one strain offers little protection against the others, a structural challenge that has stalled rhinovirus vaccine development for decades even as research continues into broader-spectrum antiviral approaches targeting shared viral mechanisms across strains.

Rhinovirus in Children in the US 2026

Average Colds Per Year, by Age Group
Children        |████████████████████████████████ 6-8
Adults          |████████████ 2-3

Source: CDC pediatric respiratory illness guidance and peer-reviewed pediatric rhinovirus surveillance studies.

Children bear a disproportionate share of the rhinovirus burden compared with adults, both in how often they get sick and in how much they contribute to household spread. School-age children introduce rhinovirus infections into their families roughly three times more frequently than working adults do, a pattern researchers attribute to close classroom contact, developing immune systems, and less consistent hand hygiene among younger kids. You can see how this pediatric pattern connects to broader respiratory illness trends in this breakdown of pediatric flu statistics, which covers how children drive transmission across multiple respiratory viruses, not just rhinovirus alone.

Infants and very young children also face a higher risk of complications beyond the typical cold symptoms adults experience. While older children and adults usually deal with a runny nose, sore throat, and cough, infants can develop otitis media, croup, or bronchiolitis, and in rarer cases, rhinovirus infection in this age group can progress toward pneumonia. That’s why the CDC specifically warns against giving over-the-counter cough and cold medicines to children under 2 unless a healthcare provider directs otherwise.

Rhinovirus Symptoms and Duration Statistics in the US 2026

Symptom Duration Distribution
Under 7 Days     |████████████████████████████████████ Most cases
7-14 Days        |████████████ Some cases
Asymptomatic     |██ Uncommon

Source: CDC rhinovirus and common cold clinical guidance, updated February 2026.

Most rhinovirus infections follow a fairly predictable course: symptoms typically resolve within a week, though the CDC notes they can stretch to two weeks in some cases before fully clearing. Asymptomatic infection, where someone carries and can spread the virus without ever feeling sick, is described as uncommon rather than typical, which distinguishes rhinovirus from some other respiratory viruses where silent spread plays a larger role in transmission.

The symptom profile itself overlaps heavily with other common respiratory infections, which is part of why rhinovirus often gets self-diagnosed rather than confirmed through lab testing. Sore throat, congestion, sneezing, and cough dominate the presentation in most cases, while fever appears more frequently among infected children than adults. Because symptoms mimic other viral illnesses so closely, official guidance recommends supportive care, rest, fluids, and symptom management rather than antibiotics, which have no effect against a viral infection like rhinovirus.

Rhinovirus Seasonality and CDC Surveillance Trends 2026

CDC National Respiratory Virus Status, September 2026
COVID-19 Activity      |████████████████████ Increasing
Influenza Activity     |██████ Low
RSV Activity           |███ Very Low
Rhinovirus/Enterovirus |███████████████████████████ Increasing Nationally

Source: CDC Respiratory Illnesses Data Channel, updated September 4, 2026.

Rhinovirus stands apart from the other viruses the CDC tracks on its weekly respiratory dashboard because it doesn’t follow the same tight winter concentration that defines flu and RSV seasons. As of early September 2026, rhinovirus/enterovirus activity is rising nationally even while influenza sits at low levels and RSV remains very low across most of the country, confirming the CDC’s own description of rhinovirus as a year-round circulator that specifically peaks in spring and late summer into fall.

That September timing lines up closely with the “back to school” period, when children returning to classrooms after summer break tend to accelerate transmission across households and communities. The CDC reviews this respiratory virus data weekly and updates its public-facing tracker with any notable shifts, which is why rhinovirus activity can show a visible late-summer uptick even in years when COVID-19, flu, and RSV all remain relatively quiet at the same point on the calendar.

Economic Cost of Rhinovirus and Common Colds in the US 2026

Annual US Cold-Related Economic Costs (USD)
Total Impact (original estimate)  |██████████████████████ $40 billion
Inflation-Adjusted Estimate       |█████████████████████████████ $56 billion+
Direct Medical Costs              |███████████ $17 billion
Indirect Costs                    |██████████████ $22.5 billion

Source: University of Michigan Health System cold-cost study, Archives of Internal Medicine, with Bureau of Labor Statistics inflation adjustment.

The $40 billion figure remains the most frequently cited baseline for the common cold’s total economic footprint in the United States, built from a large household survey measuring both direct healthcare spending and the broader productivity losses tied to getting sick. Since rhinovirus causes more than half of all colds, a proportional share of that entire cost burden traces back to this single virus family, even though public health attention rarely frames it that way compared with headline-grabbing illnesses like flu or COVID-19.

Adjusted for inflation, that same economic burden would exceed $56 billion in more recent dollars, and even that updated figure likely understates the full cost given how much healthcare pricing and medication costs have shifted since the original study period. The breakdown between direct medical costs and indirect productivity losses also shows that the bigger financial hit doesn’t come from doctor visits or medicine, it comes from the ripple effect of missed work and school days across the wider economy.

Missed Work and School Days from Rhinovirus Colds in the US 2026

Annual Missed Days (millions)
School Days Missed (children)      |████████████████████████████████████████ 189
Parent Workdays (child care)       |███████████████████████████ 126
Employee Sick Days (self)          |███████████████ 70

Source: University of Michigan Health System national household survey and Journal of Occupational and Environmental Medicine productivity research.

The scale of missed school days, 189 million annually, makes the common cold one of the single largest disruptors of the US education system, exceeding what most other childhood illnesses cause combined. That number cascades directly into the workplace too, since 126 million additional parent workdays get lost purely to childcare needs when a sick child has to stay home, a hidden cost that rarely shows up in headline healthcare spending figures but hits household income just as directly.

Adults getting sick themselves account for a further 70 million missed workdays annually, and researchers note that colds account for as much as 40% of total time lost from work across the employed population. Interestingly, most people don’t actually stay home when they catch a cold; workplace studies have found the majority of workers continue attending work while symptomatic, which keeps the missed-workday figures lower than they might otherwise be, but likely increases workplace transmission in the process.

That “working while sick” pattern carries its own hidden cost. Researchers estimate it costs employers roughly twice as much in lost productivity when an employee comes to work with cold symptoms compared with staying home entirely, since impaired concentration, slower task completion, and the risk of infecting coworkers all combine to outweigh the value of simple attendance. Despite that, surveys consistently find that a large majority of workers say they continue attending work or school even while experiencing symptoms of a cold or flu-like illness.

High-Risk Groups and Complications from Rhinovirus in the US 2026

Populations at Elevated Risk of Severe Rhinovirus Illness
Asthma Patients          |████████████████████████████████ Elevated Risk
Immunocompromised        |████████████████████████████████ Elevated Risk
Infants & Young Children |██████████████████████████ Elevated Risk
Elderly Adults           |████████████████████████████ Elevated Risk

Source: CDC rhinovirus clinical guidance and peer-reviewed respiratory virus complication studies.

Rhinovirus earns its reputation as a mostly mild illness for good reason, most infections really do resolve without complication, but that reputation can obscure real risk for specific populations. Because vaccination isn’t available and no antiviral treatment exists, prevention for higher-risk groups comes down almost entirely to hand hygiene, avoiding close contact with sick individuals, and managing underlying conditions like asthma proactively, especially heading into the late-summer and fall periods when activity typically climbs. For families managing multiple childhood illness risks at once, this overview of childhood vaccine statistics covers how immunization schedules address other respiratory threats even where rhinovirus itself has no vaccine option.

For people managing asthma or chronic obstructive pulmonary disease specifically, rhinovirus infection ranks among the most common viral triggers for symptom exacerbation, sometimes serious enough to require emergency care even though the underlying viral infection itself would be mild in a person without a chronic respiratory condition. This overlap between a “minor” virus and a “major” trigger for chronic disease flare-ups is one of the more underappreciated aspects of rhinovirus’s overall public health impact, and it’s part of why symptom tracking for at-risk groups matters even during a virus season the general public barely notices. For general comparison against another widely tracked respiratory illness, see this look at flu symptoms statistics covering how presentation and severity differ between influenza and common cold viruses like rhinovirus.

Elderly adults round out the highest-risk category, though severe outcomes remain rare relative to the overall infection count. Fatal pneumonia linked to rhinovirus infection occurs almost exclusively among elderly or immunocompromised patients rather than the general population, which is consistent with how most respiratory viruses behave: the sheer volume of infections is enormous, but severe outcomes concentrate heavily among people whose immune systems or underlying health conditions leave them least equipped to fight off even a typically mild illness.

Frequently Asked Questions About Rhinovirus Statistics in US 2026

What percentage of colds are caused by rhinovirus?

Rhinovirus causes more than 50% of all common colds in the United States, making it the single most frequent cause of the illness.

How many colds do children get per year compared to adults?

Children average 6 to 8 colds per year, while adults average 2 to 3, according to CDC and peer-reviewed cold-frequency research.

Is rhinovirus activity increasing in 2026?

Yes. As of September 4, 2026, the CDC reports rhinovirus/enterovirus activity increasing nationally, which the agency describes as an expected seasonal pattern.

How long do rhinovirus symptoms usually last?

Symptoms typically last under 7 days, though they can extend up to 2 weeks in some cases.

Is there a vaccine for rhinovirus?

No. There is currently no vaccine or specific antiviral treatment available for rhinovirus infections.

How much does the common cold cost the US economy?

The common cold costs the US economy nearly $40 billion annually in the original study estimate, or over $56 billion once adjusted for inflation.

How many school days do children miss due to colds each year?

Children miss an estimated 189 million school days annually due to colds, making it one of the leading causes of school absenteeism.

Who is at higher risk for severe rhinovirus illness?

People with asthma, weakened immune systems, chronic pulmonary disease, infants, and elderly adults face a higher risk of severe illness or complications from rhinovirus.

Can rhinovirus trigger asthma attacks?

Yes. Rhinovirus is a common viral trigger for asthma attacks and can also exacerbate chronic obstructive pulmonary disease.

How many known strains of rhinovirus are there?

There are more than 160 known rhinovirus strains, which is a major reason a vaccine has not yet been developed.

Does rhinovirus circulate all year or only in winter?

Rhinovirus circulates year-round, unlike influenza and RSV, though CDC surveillance shows it typically peaks in spring and again in late summer through fall, which explains upticks in activity outside the traditional cold-and-flu season that most people expect.

Disclaimer: This research report is compiled from publicly available sources. While reasonable efforts have been made to ensure accuracy, no representation or warranty, express or implied, is given as to the completeness or reliability of the information. We accept no liability for any errors, omissions, losses, or damages of any kind arising from the use of this report.

Email ID:

Please enable JavaScript in your browser to complete this form.

Email

Email *

SUBSCRIBE